GB9102997D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB9102997D0
GB9102997D0 GB919102997A GB9102997A GB9102997D0 GB 9102997 D0 GB9102997 D0 GB 9102997D0 GB 919102997 A GB919102997 A GB 919102997A GB 9102997 A GB9102997 A GB 9102997A GB 9102997 D0 GB9102997 D0 GB 9102997D0
Authority
GB
United Kingdom
Prior art keywords
pct
sec
date
ring
therapeutic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919102997A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Pfizer Inc
Original Assignee
Pfizer Ltd Great Britain
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd Great Britain, Pfizer Inc filed Critical Pfizer Ltd Great Britain
Priority to GB919102997A priority Critical patent/GB9102997D0/en
Publication of GB9102997D0 publication Critical patent/GB9102997D0/en
Priority to AT92902889T priority patent/ATE109482T1/de
Priority to CA002099381A priority patent/CA2099381C/en
Priority to ES92902889T priority patent/ES2059212T3/es
Priority to PCT/EP1992/000163 priority patent/WO1992014734A1/en
Priority to DK92902889.2T priority patent/DK0572425T3/da
Priority to FI933531A priority patent/FI933531L/fi
Priority to US08/087,736 priority patent/US5358953A/en
Priority to RU93054165A priority patent/RU2114845C1/ru
Priority to BR9205615A priority patent/BR9205615A/pt
Priority to KR1019930702352A priority patent/KR970005302B1/ko
Priority to JP4503504A priority patent/JP2506541B2/ja
Priority to HU9302327A priority patent/HUT65947A/hu
Priority to PL92300296A priority patent/PL169304B1/pl
Priority to DE69200304T priority patent/DE69200304T2/de
Priority to EP92902889A priority patent/EP0572425B1/en
Priority to AU11683/92A priority patent/AU650322B2/en
Priority to IL10088792A priority patent/IL100887A/en
Priority to TW081100891A priority patent/TW227000B/zh
Priority to EG8792A priority patent/EG20085A/xx
Priority to MX9200589A priority patent/MX9200589A/es
Priority to MYPI92000223A priority patent/MY108437A/en
Priority to NZ241597A priority patent/NZ241597A/en
Priority to YU14392A priority patent/YU48238B/sh
Priority to IE920449A priority patent/IE65125B1/en
Priority to ZA921005A priority patent/ZA921005B/xx
Priority to CS92425A priority patent/CZ280504B6/cs
Priority to CN92100974A priority patent/CN1040326C/zh
Priority to NO932889A priority patent/NO300592B1/no
Priority to HU95P/P00175P priority patent/HU211202A9/hu
Priority to FI973558A priority patent/FI101225B1/fi
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Prostheses (AREA)
  • Steroid Compounds (AREA)
GB919102997A 1991-02-13 1991-02-13 Therapeutic agents Pending GB9102997D0 (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
GB919102997A GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents
KR1019930702352A KR970005302B1 (ko) 1991-02-13 1992-01-24 이미다조피린딘 혈소판 활성 인자/히스타민(paf/h₁)길항제
DE69200304T DE69200304T2 (de) 1991-02-13 1992-01-24 Imidazopyridin-PAF/H1-Antagonisten.
EP92902889A EP0572425B1 (en) 1991-02-13 1992-01-24 Imidazopyridine paf/h 1 antagonists
ES92902889T ES2059212T3 (es) 1991-02-13 1992-01-24 Antagonistas paf/h1 imidazopiridina.
PCT/EP1992/000163 WO1992014734A1 (en) 1991-02-13 1992-01-24 Imidazopyridine paf/h1 antagonists
DK92902889.2T DK0572425T3 (da) 1991-02-13 1992-01-24 Imidazopyridin-PAF/H1-antagonister
FI933531A FI933531L (fi) 1991-02-13 1992-01-24 Imidazopyridin paf/h1 antagonister
US08/087,736 US5358953A (en) 1991-02-13 1992-01-24 Imidazopyridine PAF/H1 antagonists
RU93054165A RU2114845C1 (ru) 1991-02-13 1992-01-24 Производные имидазопиридина или их фармацевтически приемлемые соли, способ их получения и фармацевтическая композиция, проявляющая антагонистическую активность в отношении гистамина (h1)
BR9205615A BR9205615A (pt) 1991-02-13 1992-01-24 Imidazopiridinas antagonistas de PAF/H1.
CA002099381A CA2099381C (en) 1991-02-13 1992-01-24 Imidazopyridine paf/h _antagonists
JP4503504A JP2506541B2 (ja) 1991-02-13 1992-01-24 イミダゾピリジンｐａｆ／ｈ▲下１▼拮抗薬
HU9302327A HUT65947A (en) 1991-02-13 1992-01-24 Imidazo-pyridine - derivatives with paf/h1 antagonist activity and pharmaceutical compositions containing them and process for the production thereof
PL92300296A PL169304B1 (pl) 1991-02-13 1992-01-24 Sposób wytwarzania nowych pochodnych imidazopirydyny PL PL
AT92902889T ATE109482T1 (de) 1991-02-13 1992-01-24 Imidazopyridin-paf/h1-antagonisten.
AU11683/92A AU650322B2 (en) 1991-02-13 1992-01-24 Imidazopyridine PAF/H1 antagonists
IL10088792A IL100887A (en) 1991-02-13 1992-02-06 Imidazopyridines process for their preparation and paf/h1 antagonist compositions containing them
TW081100891A TW227000B (https=) 1991-02-13 1992-02-10
EG8792A EG20085A (en) 1991-02-13 1992-02-10 Process for preparing of imidazopyridine PAF/H2 antagonists
MX9200589A MX9200589A (es) 1991-02-13 1992-02-11 Imidazopiridinas antagonistas de fap/h1. imidazopiridinas antagonistas de fap/h1.
CS92425A CZ280504B6 (cs) 1991-02-13 1992-02-12 Imidazopyridinové deriváty jako antagonisty PAF/H1, způsob přípravy těchto sloučenin a použití
ZA921005A ZA921005B (en) 1991-02-13 1992-02-12 Imidazopyridine PAF/H 1 antagonists.
NZ241597A NZ241597A (en) 1991-02-13 1992-02-12 Imidazopyridine paf/h 1 antagonists
YU14392A YU48238B (sh) 1991-02-13 1992-02-12 Derivti imidazopiridina, postupak za dobijanje smeša sa njima i postupak za dobijanje derivata imidazopiridina
IE920449A IE65125B1 (en) 1991-02-13 1992-02-12 Imidazopyridine PAF/H1 antagonists
MYPI92000223A MY108437A (en) 1991-02-13 1992-02-12 Imidazopyridine paf/h1 antagonists
CN92100974A CN1040326C (zh) 1991-02-13 1992-02-13 咪唑并吡啶paf/h1拮抗剂的制备方法
NO932889A NO300592B1 (no) 1991-02-13 1993-08-13 Imidazopyridin PAF/H1 antagonister
HU95P/P00175P HU211202A9 (en) 1991-02-13 1995-06-09 Imidazopyridine paf/h 1 antagonists
FI973558A FI101225B1 (fi) 1991-02-13 1997-08-29 Menetelmä terapeuttisesti käyttökelpoisten 2-metyyli-imidatso[4,5-c]pyrid-1-yylijohdannaisten valmistamiseksi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919102997A GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB9102997D0 true GB9102997D0 (en) 1991-03-27

Family

ID=10689943

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919102997A Pending GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents

Country Status (29)

Country Link
US (1) US5358953A (https=)
EP (1) EP0572425B1 (https=)
JP (1) JP2506541B2 (https=)
KR (1) KR970005302B1 (https=)
CN (1) CN1040326C (https=)
AT (1) ATE109482T1 (https=)
AU (1) AU650322B2 (https=)
BR (1) BR9205615A (https=)
CA (1) CA2099381C (https=)
CZ (1) CZ280504B6 (https=)
DE (1) DE69200304T2 (https=)
DK (1) DK0572425T3 (https=)
EG (1) EG20085A (https=)
ES (1) ES2059212T3 (https=)
FI (1) FI933531L (https=)
GB (1) GB9102997D0 (https=)
HU (2) HUT65947A (https=)
IE (1) IE65125B1 (https=)
IL (1) IL100887A (https=)
MX (1) MX9200589A (https=)
MY (1) MY108437A (https=)
NO (1) NO300592B1 (https=)
NZ (1) NZ241597A (https=)
PL (1) PL169304B1 (https=)
RU (1) RU2114845C1 (https=)
TW (1) TW227000B (https=)
WO (1) WO1992014734A1 (https=)
YU (1) YU48238B (https=)
ZA (1) ZA921005B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
AU3186395A (en) * 1994-08-10 1996-03-07 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives as dual histamine (h1) and platelet activating factor (paf) antagonists
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
AU698487B2 (en) * 1995-08-05 1998-10-29 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
WO2002011676A2 (en) 2000-08-04 2002-02-14 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
EP1622633B1 (en) 2003-05-15 2016-02-24 Ampio Pharmaceuticals, Inc. Treatment of t-cell mediated diseases
US7687515B2 (en) * 2006-01-17 2010-03-30 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
ES2527588T3 (es) 2008-01-30 2015-01-27 Nippon Zoki Pharmaceutical Co., Ltd. Derivado de piperidina
EP2300011A4 (en) 2008-05-27 2012-06-20 Dmi Life Sciences Inc THERAPEUTIC PROCESSES AND COMPOUNDS
JP5978296B2 (ja) * 2011-06-28 2016-08-24 フジアン・ミンドン・レジュヴネイション・ファーマスーティカル・カンパニー・リミテッド 抗アレルギ性ベンゾシクロヘプタチオフェン誘導体
EP3721884A1 (en) 2011-10-10 2020-10-14 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease with da-dkp (= aspartyl-alanyl diketopiperazine)
SG10201608087WA (en) 2011-10-10 2016-11-29 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
CN103841974A (zh) * 2011-10-28 2014-06-04 安皮奥制药股份有限公司 鼻炎的治疗
CA2906864A1 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
CA2958080A1 (en) 2014-08-18 2016-02-25 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (https=) * 1963-04-24
AU616508B2 (en) * 1988-03-15 1991-10-31 G.D. Searle & Co. Benzyl-imidazo (4,5-c) pyridines
SG44477A1 (en) * 1988-04-28 1997-12-19 Schering Corp Fused polycyclic compounds compositions methods of manufacture and their use as paf antaginists anthihistamines and/or antiinflammatory agents
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
ES2061247T3 (es) * 1990-05-09 1994-12-01 Pfizer Imidazo (4,5-c) piridinas con actividad antagonista del paf.

Also Published As

Publication number Publication date
CN1064275A (zh) 1992-09-09
FI933531A0 (fi) 1993-08-10
IL100887A0 (en) 1992-11-15
ZA921005B (en) 1993-08-12
IE65125B1 (en) 1995-10-04
CA2099381C (en) 1996-07-09
CA2099381A1 (en) 1992-08-14
ATE109482T1 (de) 1994-08-15
US5358953A (en) 1994-10-25
JP2506541B2 (ja) 1996-06-12
DK0572425T3 (da) 1994-09-12
EG20085A (en) 1997-05-31
HUT65947A (en) 1994-08-29
HU211202A9 (en) 1995-11-28
MX9200589A (es) 1992-10-01
CZ280504B6 (cs) 1996-02-14
HU9302327D0 (en) 1993-10-28
ES2059212T3 (es) 1994-11-01
JPH06504992A (ja) 1994-06-09
EP0572425B1 (en) 1994-08-03
NO300592B1 (no) 1997-06-23
AU1168392A (en) 1992-09-15
CS42592A3 (en) 1992-09-16
NZ241597A (en) 1993-04-28
DE69200304D1 (de) 1994-09-08
EP0572425A1 (en) 1993-12-08
BR9205615A (pt) 1994-05-17
NO932889L (no) 1993-08-13
PL169304B1 (pl) 1996-06-28
RU2114845C1 (ru) 1998-07-10
YU14392A (sh) 1994-11-15
IL100887A (en) 1996-01-19
MY108437A (en) 1996-09-30
WO1992014734A1 (en) 1992-09-03
TW227000B (https=) 1994-07-21
FI933531A7 (fi) 1993-08-10
KR970005302B1 (ko) 1997-04-15
AU650322B2 (en) 1994-06-16
YU48238B (sh) 1997-08-22
NO932889D0 (no) 1993-08-13
IE920449A1 (en) 1992-08-12
CN1040326C (zh) 1998-10-21
DE69200304T2 (de) 1994-12-08
FI933531L (fi) 1993-08-10

Similar Documents

Publication Publication Date Title
GB9102997D0 (en) Therapeutic agents
ES2162061T3 (es) Derivados de piperidina como antagonistas de la neuroquinina.
BG105513A (en) Substituted benzopyran analogs for the treatment of inflammation
YU48426B (sh) Novi supstituisani pirazolilpirazoli, postupak njihovog dobijanja, medjuproizvodi za njihovo dobijanje i primena kao sredstava sa herbicidnim delovanjem
YU84791A (sh) Biciklicni 1-aza-cikloalkalni
PT1158973E (pt) Utilizacao de derivados de sulfamato para o tratamento dos disturbios do controlo de impulsos
MXPA02011417A (es) 1-aminoalquil-lactamas sustituidas y su uso como antagonistas de receptores muscarinicos.
DK1109817T3 (da) Phosphohalogenhydriner, deres fremstilling og anvendelse
RU93054165A (ru) Производные имидазопиридина, способ их получения, фармацевтическая композиция, способ лечения
FI922341A0 (fi) Piperidin- och pyrrolidinderivat.
ES2110260T3 (es) Androstenonas.
EP0604354A3 (en) Antidepressant and anti-Parkinson's disease compounds.
DE69403084D1 (de) Benzopyrane und diese enthaltende pharmazeutische zusammenstellungen
ATE64373T1 (de) Muscarin-rezeptor-antagonisten.
UA41350C2 (uk) Похідна морфоліну або її фармацевтично прийнятна сіль та фармацевтична композиція на її основі
YU4393A (sr) Supstituisani heksahidroazepinoni i tetrahidrobenzazepinoni
ES2095995T3 (es) Procedimiento para la obtencion de 2,2-difluorbenzo(1,3)dioxol-carbaldehidos y nuevos productos intermedios.
TR199901395T2 (xx) Yeni karboksi ikameli siklik karboksamid t�revleri.
MX9606654A (es) Derivados de alaquildiamina substituida y su uso como antagonistas de taquicinina.
ATE514420T1 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und endothelinantagonisten
FI973558L (fi) Menetelmä terapeuttisesti käytt¦kelpoisten 2-metyyli-imidatsoÄ4,5-cÜpyrid-1-yylijohdannaisten valmistamiseksi
PT100223A (pt) Processo para a preparacao de imidazopiridinas antagonistas de paf/h1
ATE110367T1 (de) Kalziumantagonisten.
DE69001794D1 (de) Phenothiazinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE271867T1 (de) Behandlung der harninkontinenz und zusammenstellung dafür